Trace Biosciences, Inc., a clinical-stage biotechnology company developing nerve-targeted imaging agents, today announced that the U.S. Food and Drug Administration (FDA) has approved its ...
As issues over unauthorized medicine have been coming to light recently, the Food and Drug Administration has rolled out an ...